Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT01728402

Pathogenesis of Hematologic Malignancies

Pathogenesis of Acute Leukemia, Lymphoproliferative Disorders, and Myeloproliferative Disorders

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
5,000 (estimated)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
All
Age
1 Year
Healthy volunteers
Not accepted

Summary

The cause of blood and bone marrow cancers is poorly understood; however, most research focuses on how cancer cells grow and develop. Because the causes of these cancers are unknown, current treatments may be unnecessarily harsh and often do not provide a cure. Identifying the causes of blood cancers would allow for the development of treatments that are more likely to provide a cure. To find the causes of blood and bone marrow cancers, we will look for specific cancer cell abnormalities that are responsible for cancer cell growth. We will then look to see if drugs that can reverse these abnormalities can kill cancer cells.

Conditions

Interventions

TypeNameDescription
PROCEDUREblood draw, bone marrow procedure, or tissue biopsy

Timeline

Start date
2008-09-01
First posted
2012-11-19
Last updated
2026-02-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01728402. Inclusion in this directory is not an endorsement.

Pathogenesis of Hematologic Malignancies (NCT01728402) · Clinical Trials Directory